Continous Glucose Monitoring in Neonates at Risk of Hypoglycaemia- a Feasibility Study

NCT07375615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-01-29

No results posted yet for this study

Summary

The study's main purpose is to test feasibility of Continous Glucose montoring in Neonates during the first 72 hrs.

Conditions

Interventions

DEVICE

Continous glucose monitor

Aplication of CGM device on neonates upper tigh

Sponsors & Collaborators

  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Dag Helge Froisland, MD, PhD · Inland Norway University of Applied Sciences

Eligibility

Min Age
0 Hours
Max Age
5 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-06-30
Completion
2025-11-12
FDA Device
Yes

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07375615 on ClinicalTrials.gov